Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong...

Published on 17 Dec 2024 on Benzinga · via Yahoo Finance

Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights Significantly high institutional ownership implies Aquestive Therapeutics' stock pri...

Simply Wall St. · via Yahoo Finance 27 Jan 2025

Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company...

Benzinga · via Yahoo Finance 17 Dec 2024

It hasn't been the best quarter for Aquestive Therapeutics, Inc. (NASDAQ:AQST) shareholders, sinc...

Simply Wall St. · via Yahoo Finance 17 Dec 2024

Aquestive Therapeutics Inc (NASDAQ:AQST) is set to release its Q3 2024 earnings on Nov 5, 2024. T...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

Aquestive Therapeutics Inc (NASDAQ:AQST) is set to release its Q3 2024 earnings on Nov 4, 2024. T...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript May 8, 2024 Aquestive...

Insider Monkey via Yahoo Finance 10 May 2024

Last week, you might have seen that Aquestive Therapeutics, Inc. (NASDAQ:AQST) released its first...

Simply Wall St. via Yahoo Finance 9 May 2024

Shares of Taysha Gene Therapies, Inc. TSHA rose sharply in today’s pre-market trading after the ...

Benzinga 21 Mar 2024

Shares of Lifecore Biomedical, Inc. LFCR fell sharply during Wednesday’s session after the comp...

Benzinga 21 Mar 2024

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% ...

Benzinga 20 Mar 2024